NRSN Neurosense Therapeutics Ltd
Company Analysis
Latest News
🔴 Neurosense Therapeutics is trading 12.1% down
Neurosense Therapeutics is trading 12.1% lower at $4.20 on September 30, 2026; no company-specific catalyst was identified. - Shares closed at $4.78 on...
🔴 Neurosense Therapeutics is trading 9% down in pre-market with no identified company-specific catalyst
Neurosense Therapeutics is trading 9.00% lower at $4.35, with no new company-specific catalyst identified for the September 30 pre-market decline. - The...
🔴 Neurosense Therapeutics is trading 13.56% down
Neurosense Therapeutics is trading at $4.40, down 13.56%, with no clear company-specific catalyst identified for the September 29 decline. - The latest...
🔴 Neurosense Therapeutics is trading 7.27% down
Neurosense Therapeutics is trading 7.27% lower at $4.72, with no clear company-specific explanation identified for the September 29 decline. - Latest company...
🔴 Neurosense Therapeutics is trading 5.7% down in after-hours trading as all three major U.S. indexes fell
Neurosense Therapeutics is trading 5.7% lower at $4.80 in after-hours trading amid broader market weakness. - It closed September 28 at $5.09. Reuters...
🔴 Neurosense Therapeutics is trading 12.2% down amid broader risk-off conditions
Neurosense Therapeutics is trading 12.2% lower at $6.11 amid broader risk-off conditions. - No company-specific announcement dated September 28 was found; the...
🔴 Neurosense Therapeutics is trading 5% down on September 28, 2026, amid broader risk-off market sentiment
Neurosense Therapeutics is trading at $6.60, down 5.04%, amid broader risk-off sentiment; no company-specific catalyst is confirmed. - The shares compare with...
🟢 Neurosense Therapeutics is trading 7.9% up in pre-market with no identified company-specific catalyst
Neurosense Therapeutics is trading 7.9% up at $7.50 in pre-market on September 28; no separate company-specific catalyst was identified. - The September 25...
🔴 Neurosense Therapeutics is trading 5.1% down today as crude oil and Treasury yields pressured valuations
Neurosense Therapeutics is trading 5.1% down at $6.82, primarily amid broader risk-off conditions. - On September 23, 2026, biotechnology stocks gained 2.07%,...
🟢 Neurosense Therapeutics is trading 11.18% up today amid biotech optimism around AI-enabled drug discovery
Neurosense Therapeutics is trading at $7.36 (+11.18%) mainly amid a broader biotech-sector rally. - No new company-specific announcement clearly explains the...
🟢 Neurosense Therapeutics is trading 5.29% up today without a clear catalyst
Neurosense Therapeutics is trading 5.29% up at $6.97 after closing at $6.62 on September 21, 2026; no new company-specific announcement clearly explains the...
🟢 Neurosense Therapeutics is trading 7.2% up today on broader market strength
Neurosense Therapeutics is trading 7.2% up at $6.81, supported by stronger broader markets. - The move follows a 5.51% decline to $6.35 on September 18. -...
🟢 Neurosense Therapeutics is trading 8% up in pre-market as S&P 500 and NASDAQ Composite rise
Neurosense Therapeutics is trading at $6.86, up 8.03% in pre-market with the move best attributed to broad risk-on sentiment. - S&P 500 is up 0.65% and NASDAQ...
🟢 Neurosense Therapeutics is trading 13.37% up today amid a broader biotechnology rally
Neurosense Therapeutics is trading 13.37% up at $6.91, amid a broader risk-on session lifting biotechnology stocks. - Major U.S. indexes are higher as...
🟢 Neurosense Therapeutics is trading 6.6% up today amid stronger market and biotech gains
Neurosense Therapeutics is trading 6.6% up now at $6.50, supported primarily by stronger market sentiment and advancing biotechnology stocks. - No new...
🟢 Neurosense Therapeutics is trading 5% up in pre-market as U.S. futures point higher
Neurosense Therapeutics is trading 5% up at $6.40 as U.S. futures point to a firmer pre-market tone. - S&P 500, Nasdaq Composite, and Dow Jones futures are...
🔴 Neurosense Therapeutics is trading 14% down today following 1-for-20 reverse stock split
Neurosense Therapeutics is trading 14.01% down now at $6.04 after heightened volatility following its 1-for-20 reverse stock split, effective September 14,...
🔴 Neurosense Therapeutics is trading 6.4% down today after 1-for-20 reverse stock split
Neurosense Therapeutics is trading 6.4% down at $6.58 amid a broader biotech selloff. - The XBI is down 2.11% during the September 16, 2026 session; decline...
🟢 Neurosense Therapeutics is trading 5% up today after 1-for-20 reverse stock split
Neurosense Therapeutics is trading 5.26% up now at $7.40 following extreme volatility after its 1-for-20 reverse stock split, effective September 14, 2026. -...
🔴 Neurosense Therapeutics is trading 10.24% down in pre-market after its 1-for-20 reverse stock split
Neurosense Therapeutics is trading 10.24% down now at $6.31 after a highly volatile session following its 1-for-20 reverse stock split, effective September 14,...